Cyanobacterial Cyclopeptides as Lead Compounds to Novel Targeted Cancer Drugs

por Sainis, Ioannis, Fokas, Demosthenes, Vareli, Katerina, Tzakos, Andreas G., Kounnis, Valentinos, Briasoulis, Evangelos
Publicado em 2010

Targeting Oncogenic Protein-Protein Interactions by Diversity Oriented Synthesis and Combinatorial Chemistry Approaches

por Tzakos, Andreas G., Fokas, Demosthenes, Johannes, Charlie, Moussis, Vassilios, Hatzimichael, Eleftheria, Briasoulis, Evangelos
Publicado no Molecules (2011)

Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule

por Argyros, Orestis, Karampelas, Theodoros, Varela, Aimilia, Asvos, Xenophon, Papakyriakou, Athanasios, Agalou, Adamantia, Beis, Dimitris, Davos, Constantinos H., Fokas, Demosthenes, Tamvakopoulos, Constantin
Publicado no Oncotarget (2017)

Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease

por Spathis, Athanasios D., Asvos, Xenophon, Ziavra, Despina, Karampelas, Theodoros, Topouzis, Stavros, Cournia, Zoe, Qing, Xiaobing, Alexakos, Pavlos, Smits, Lisa M., Dalla, Christina, Rideout, Hardy J., Schwamborn, Jens Christian, Tamvakopoulos, Constantin, Fokas, Demosthenes, Vassilatis, Demetrios K.
Publicado no Proc Natl Acad Sci U S A (2017)